REQUEST A DEMO
Total
USD $0.00
Search more companies

Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (河北常山生化药业股份有限公司) (China)

Main Activities: Biological Product (except Diagnostic) Manufacturing
Full name: Hebei Changshan Biochemical Pharmaceutical Co., Ltd. Profile Updated: March 01, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Chinese Download a sample report

Hebei Changshan Biochemical Pharmaceutical Co., Ltd is a biochemical pharmaceutical company operating within the biomedical industry, focusing on the research, development, production, sale, import, and export of pharmaceutical products. Its primary target market is the hepatitis sector, offering products such as low-molecular hepatin injections and medications for diabetes and tumors. Hebei Changshan claims to have developed biopharmaceutical technologies and research platforms to support its innovation efforts. The company targets over a billion yuan in sales.

Headquarters
No. 71, Menglong Street, South District, Zhengding High-tech Industrial Development Zone, Zhengding County, Zhengding Pilot Free Trade Zone, Shijiazhuang City, Hebei Province
Shijiazhuang; Hebei; Postal Code: 050800

Contact Details: Purchase the Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (河北常山生化药业股份有限公司) report to view the information.

Website: http://www.hbcsbio.com

Basic Information
Total Employees:
Purchase the Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (河北常山生化药业股份有限公司) report to view the information.
Outstanding Shares:
Purchase the Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (河北常山生化药业股份有限公司) report to view the information.
Registered Capital:
Purchase the Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (河北常山生化药业股份有限公司) report to view the information.
Financial Auditors:
Purchase the Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (河北常山生化药业股份有限公司) report to view the information.
Incorporation Date:
September 28, 2000
Key Executives
Purchase this report to view the information.
General Manager
Purchase this report to view the information.
Deputy General Manager
Purchase this report to view the information.
Deputy General Manager
Purchase this report to view the information.
Deputy General Manager
Purchase this report to view the information.
Deputy General Manager
Ownership Details
Purchase this report to view the information.
30.54%
Purchase this report to view the information.
2.27%
Purchase this report to view the information.
1.52%
Purchase this report to view the information.
0.81%
Purchase this report to view the information.
0.62%
Subsidiaries
CHANGSHAN EUROPE SRL
100%
Changshan Biochemical Pharmaceutical (Jiangsu) Co., Ltd.
100%
Changshan Pharmaceutical (Hong Kong) Co., Ltd.
100%
Company Performance
Financial values in the chart are available after Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (河北常山生化药业股份有限公司) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
-13.11%
Total operating revenue
-12.9%
Operating Profit/Loss (EBIT)
4.88%
Net Profit/Loss for the Period
-104.93%
Total Assets
-0.61%
Total Equity
-16.56%
Operating Profit Margin (ROS)
-0.7%
Net Profit Margin
-4.81%
Return on Equity (ROE)
-2.28%
Debt/Equity
40.56%
Quick Ratio
-0.09%
Cash Ratio
-0.06%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?